Defending Against Risking Cyber Attacks on Pharmaceutical Companies
Gain prescriptive guidance to pre-empt attacks and achieve compliance.
Pharmaceutical companies are prime targets for cyber attacks given the significance and prevalence of their intellectual property. The consequences of a successful breach are concerning, ranging from stolen IP, repeating clinical trials, contaminated drugs, physical damage and downtime, litigation and lost revenue. IT security is top of mind for pharmaceutical companies but they also must comply with FDA 21 CFR Part 11, the regulation that spell our control and audit requirements for clinical trial systems. Whether it is a database of clinical trial data or drug formulas, or an industrial control system used in the manufacturing of pharmaceuticals, Tripwire offers security configuration management, vulnerability management and log management capabilities to protect critical systems.
This solution brief speaks to these challenges and offers perspective guidance on Tripwire can help. It includes a detailed matrix on the most important FDA requirements and how Tripwire helps.
Complete the form to learn how you as pharmaceutical can preempt attacks on your system and data to avoid significant damage to your critical assets.